0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 1-20 of 83 Articles
Challenges in Clinical Electrocardiography 
P. Elliott Miller, MD; Eric L. Scholten, MD; Chintan S. Desai, MD; Ryan J. Tedford, MD
A woman in her 70s presented to our hospital with progressive shortness of breath, fatigue, and lower extremity edema. Her history included nonischemic cardiomyopathy with a left ventricular ejection fraction of 25%, New York Heart Association functional class IIIb to IV heart failure, cardiac resynchronization therapy for a left bundle ...
Invited Commentary 
Jodi B. Segal, MD, MPH; Nisa M. Maruthur, MD, MHS
Berkowitz and colleagues1 assert that there is little comparative effectiveness evidence to guide initial selection of therapy for diabetes mellitus. They therefore conducted this rigorous study to determine effects attributable to initial oral glucose-lowering agents. With a retrospective cohort design using 4 years of recent claims data from a large ...
Research Letter 
Joshua J. Fenton, MD, MPH; Christoph I. Lee, MD, MSHS; Guibo Xing, PhD; Laura-Mae Baldwin, MD, MPH; Joann G. Elmore, MD, MPH
Since 2001, Medicare has reimbursed computer-aided detection (CAD) during screening mammography. The CAD software tool is used by radiologists to identify lesions suggestive of malignant disease. Research suggests that CAD use increases the rate of false-positive findings of screening mammography and the detection of ductal carcinoma in situ (DCIS).1 Increased ...
Research Letter 
Michael A. Yokell, ScB; M. Kit Delgado, MD, MS; Nickolas D. Zaller, PhD; N. Ewen Wang, MD; Samuel K. McGowan, AB; Traci Craig Green, PhD, MSc
Opioid overdose is a leading cause of injury-related mortality in the United States.1,2 However, little is known nationally regarding the characteristics of opioid overdose presentations to emergency departments (EDs).
Original Investigation 
Seth A. Berkowitz, MD, MPH; Alexis A. Krumme, MS; Jerry Avorn, MD; Troyen Brennan, MD, MPH, JD; Olga S. Matlin, PhD; Claire M. Spettell, PhD; Edmund J. Pezalla, MD, MPH; Gregory Brill, MS; William H. Shrank, MD, MSHS; Niteesh K. Choudhry, MD, PhD
Includes: Supplemental Content

Importance  Although many classes of oral glucose-lowering medications have been approved for use, little comparative effectiveness evidence exists to guide initial selection of therapy for diabetes mellitus.

Objective  To determine the effect of initial oral glucose-lowering agent class on subsequent need for treatment intensification and 4 ...

Original Investigation 
Judith I. Tsui, MD, MPH; Jennifer L. Evans, MS; Paula J. Lum, MD, MPH; Judith A. Hahn, PhD; Kimberly Page, PhD, MPH

Importance  Injection drug use is the primary mode of transmission for hepatitis C virus (HCV) infection. Prior studies suggest opioid agonist therapy may reduce the incidence of HCV infection among injection drug users; however, little is known about the effects of this therapy in younger users.

Objective...

Original Investigation 
Peter K. Lindenauer, MD, MSc; Mihaela S. Stefan, MD; Meng-Shiou Shieh, PhD; Penelope S. Pekow, PhD; Michael B. Rothberg, MD, MPH; Nicholas S. Hill, MD
Includes: Supplemental Content

Importance  Small clinical trials have shown that noninvasive ventilation (NIV) is efficacious in reducing the need for intubation and improving short-term survival among patients with severe exacerbations of chronic obstructive pulmonary disease (COPD). Little is known, however, about the effectiveness of NIV in routine clinical practice.

Objective...

They say that the most dangerous kind of ignorance is not knowing what you don’t know. It took me a long time to realize I had statin-related cognitive impairment because I had no idea what it was.
Invited Commentary 
Katherine Baicker, PhD; Meredith Rosenthal, PhD
In an era in which the term patient-centered is ubiquitous in health care, the payment and delivery systems remain stubbornly anything but. Although many proposed reforms aim to align the financial incentives faced by all of the people and institutions in the health care system with the delivery of high-value ...
Invited Commentary 
Joshua J. Gagne, PharmD, ScD
Apophenia is the perception of meaningful patterns and causal connections among random data. Are case reports of severe impulsive behaviors associated with the use of dopamine receptor agonist drugs examples of apophenia or of a causal connection between the drugs and impulse control disorders?
Invited Commentary 
Howard D. Weiss, MD; Gregory M. Pontone, MD
The discovery of striatal dopamine deficiency and the introduction of levodopa in the 1960s as treatment for the motor symptoms of Parkinson disease revolutionized neurology and neurotherapeutics. For the first time, patients with an apparently hopeless chronic degenerative brain disorder were able to regain function and return to the mainstream ...
Research Letter 
Alexis A. Krumme, MS; Niteesh K. Choudhry, MD, PhD; William H. Shrank, MD, MSHS; Troyen A. Brennan, MD, JD, MPH; Olga S. Matlin, PhD; Gregory Brill, MS; Joshua J. Gagne, PharmD, ScD
Cigarette smoking can make managing chronic diseases more difficult. For instance, in patients with certain respiratory conditions, smoking increases the risk of acute exacerbation, can worsen disease control, and may limit the effectiveness of inhaled corticosteroids.1 Similarly, by raising blood pressure, smoking can make it challenging to effectively control hypertension ...
Original Investigation 
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS

Importance  Severe impulse control disorders involving pathological gambling, hypersexuality, and compulsive shopping have been reported in association with the use of dopamine receptor agonist drugs in case series and retrospective patient surveys. These agents are used to treat Parkinson disease, restless leg syndrome, and hyperprolactinemia.

Objectives  ...

Original Investigation 
David A. Fiellin, MD; Richard S. Schottenfeld, MD; Christopher J. Cutter, PhD; Brent A. Moore, PhD; Declan T. Barry, PhD; Patrick G. O’Connor, MD, MPH

Importance  Prescription opioid dependence is increasing and creates a significant public health burden, but primary care physicians lack evidence-based guidelines to decide between tapering doses followed by discontinuation of buprenorphine hydrochloride and naloxone hydrochloride therapy (hereinafter referred to as buprenorphine therapy) or ongoing maintenance therapy.

Objective  ...

Perspective 
Jason H. Maley, MD; Erin C. Kiskis, BA
Special Communication 
Rachelle E. Bernacki, MD, MS; Susan D. Block, MD; for the American College of Physicians High Value Care Task Force
Includes: Supplemental Content

An understanding of patients’ care goals in the context of a serious illness is an essential element of high-quality care, allowing clinicians to align the care provided with what is most important to the patient. Early discussions about goals of care are associated with better quality of life, ...

Special Communication 
Harald Schmidt, PhD; Ezekiel J. Emanuel, MD, PhD

Current approaches to controlling health care costs have strengths and weaknesses. We propose an alternative, “inclusive shared savings,” that aims to lower medical costs through savings that are shared by physicians and patients. Inclusive shared savings may be particularly attractive in situations in which treatments, such as those ...

Editor's Note 
Robert Steinbrook, MD
Lung cancer, the vast majority of cases of which are caused by smoking, is the leading cause of cancer deaths in both men and women in the United States. In 2014, about 160 000 people are expected to die from lung cancer, accounting for about 27% of all cancer deaths.1 ...
Invited Commentary 
Wylie Burke, MD, PhD; Kenneth Thummel, PhD
Individual differences in response to medications are an important challenge in clinical practice. Drugs that work well for some patients are ineffective for others, and individuals vary markedly in their experience of adverse drug reactions. Some of this variation is associated with individual differences in the genes involved in drug ...
Invited Commentary  FREE
Steven A. Schroeder, MD
The most striking statistic on the harms of smoking is the number of estimated deaths from tobacco exposure. There are an estimated 480 000 annual deaths caused by tobacco use in the United States,1 and approximately 5.7 million deaths each year globally, making smoking the most common cause of preventable ...

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal